Association Between Door to Balloon Time and Reperfusion with Left Ventricular Function and Heart Failure in Patients With ST Segment Elevated Myocardial Infarction Treated with Primary Percutaneous Intervention

Muhammad  Taha; Sajjad  Ahmad; Muhammad  Javeed; Muhammad  Kamran; Hamayon .; Syed Jalal Ud  Din

doi:10.51253/pafmj.v75iSUPPL-6.13276

Authors

Muhammad Taha Department of Cardiology, Punjab Institute of Cardiology, Lahore Pakistan
Sajjad Ahmad Department of Cardiology, Punjab Institute of Cardiology, Lahore Pakistan
Muhammad Javeed Department of Cardiology, Punjab Institute of Cardiology, Lahore Pakistan
Muhammad Kamran Department of Cardiology, Punjab Institute of Cardiology, Lahore Pakistan
Hamayon . Department of Cardiology, Punjab Institute of Cardiology, Lahore Pakistan
Syed Jalal Ud Din Department of Cardiology, Punjab Institute of Cardiology, Lahore Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75iSUPPL-6.13276

Keywords:

Door to balloon time, heart failure, STEMI.

Abstract

Objective: To determine the association between prolonged D2B time and heart failure in patients with STEMI treated with primary PCI.

Study Design: Prospective longitudinal study

Place and Duration of Study: Cardiology department of Punjab Institute of Cardiology, Lahore Pakistan, from Oct 2024 to Feb 2025.

Methodology: This study was carried out on 120 patients diagnosed with acute STEMI undergoing primary PCI after taking informed consent. Data was collected using pre-designed proforma. Patients were categorized into two groups based on door-to-balloon time, to compare the incidence of heart failure at 48 hours post-PCI. Relative risk was calculated, and data analysis was performed using SPSS version 26, with p-value <0.05 considered significant.

Results: Heart failure was observed in 23% exposed patients vs. 15% non-exposed patients, relative risk of heart failure in exposed group was 1.556 (95% CI: 0.730–3.317).

Conclusion: This study suggests that prolonged door-to-balloon time is linked to higher frequency of heart failure in patients with STEMI undergoing primary PCI, with relative risk indicating increased likelihood of heart failure in those with delayed intervention.

Downloads

Download data is not yet available.

References

1. Tern PJW, Ho AKH, Sultana R, Ahn Y, Almahmeed W, Brieger D, et al. Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysis. Eur Heart J Qual Care Clin Outcomes 2021; 7(1): 6-17.

https://doi.org/10.1093/ehjqcco/qcaa057

2. Karthikeyan T, Raja M, Radha D, Gaur T A, Geetha J, Sakthivadivel V et al. Risk factors and inflammatory markers in acute coronary syndrome-ST elevation myocardial infarction (STEMI). HMBCI 2023; 44(2): 115-20.

https://doi.org/10.1515/hmbci-2021-0106

3. Mile E, Balla I. Efficacy of thrombolytic therapy in the treatment of Acute Myocardial Infarction (AMI). Int J Med Sci 2022; 7(13-14): 80-86. Clinical benefits of thrombolytic therapy in acute myocardial infarction - American Journal of Cardiology

4. Alyamani M, Campbell S, Navarese E, Welsh RC, Bainey KR. Safety and efficacy of intracoronary thrombolysis as adjunctive therapy to primary PCI in STEMI: a systematic review and meta-analysis. Can J Cardiol 2021; 37(2): 339-346.

https://doi.org/10.1016/j.cjca.2020.03.034

5. Abdin A, Anker SD, Butler J, Coats AJS, Kindermann I, Lainscak M, et al. ‘Time is prognosis’ in heart failure: time-to-treatment initiation as a modifiable risk factor. ESC Heart Failure 2021; 8(6): 4444-53.

https://doi.org/10.1002/ehf2.13646

6. Costa R, Trêpa M, Oliveira M, Frias A, Campinas A, Luz A, et al. Heart failure incidence following ST-elevation myocardial infarction. Am J Cardiol 2022; 164: 14-20.

https://doi.org/10.1016/j.amjcard.2021.10.035

7. Jenča D, Melenovský V, Stehlik J, Staněk V, Kettner J, Kautzner J, et al. Heart failure after myocardial infarction: incidence and predictors. ESC heart failure 2021; 8(1): 222-37.

https://doi.org/10.1002/ehf2.13144

8. Yiadom MYA, Olubowale OO, Jenkins CA, Miller KF, West JL, Vogus TJ, et al. Understanding timely STEMI treatment performance: a 3‐year retrospective cohort study using diagnosis‐to‐balloon‐time and care subintervals. Journal of the American College of Emergency Physicians Open 2021; 2(1): e12379. https://doi.org/10.1002/emp2.12379

9. Khowaja S, Ahmed S, Kumar R, Shah JA, Khan KA, Khan NU, et al. Time to think beyond door to balloon time: significance of total ischemic time in STEMI. Egypt Heart J 2021; 73: 1-7.

https://doi.org/10.1186/s43044-021-00221-1

10. Zamani B, Ghadimi S, Moradoghli F, Chenaghlou M, Separham A, Amirajam Z, et al. Associated factors with delayed door to balloon time in STEMI Patients. Int J Cardiovasc Pract 2021; 6: 131479. https://doi.org/10.29252/ijcp-31535

11. Dadu rt, el-refai m, davis a, bobek j, chiang i-h, alam m, et al. Impact of shorter door to balloon time on left ventricular ejection fraction in stemi patients who present early to hospital. J am coll cardiol 2016; 67(13_supplement): 657. Impact of shorter door to balloon time on left ventricular ejection fraction in stemi patients who present early to hospital | JACC

12. Bauer T, Zeymer U, Diallo A, Vicaut E, Bolognese L, Cequier A, et al. Impact of preprocedural TIMI flow on clinical outcome in low‐risk patients with ST‐elevation myocardial infarction: Results from the ATLANTIC study. Catheter Cardiovasc Interv 2020; 95(3): 494-500.

https://doi.org/10.1002/ccd.28318

13. Oliveira CC, Vilela F, Braga C, Costa J, Marques J. ST-segment elevation myocardial infarction differences between genders–a single center retrospective analysis. Arquivos Brasileiros de Cardiologia 2023; 120: e20211040.

https://doi.org/10.36660/abc.20211040

14. Kuehnemund L, Koeppe J, Feld J, Wiederhold A, Illner J, Makowski L, et al. Gender differences in acute myocardial infarction—A nationwide German real-life analysis from 2014 to 2017. Clin Cardiology 2021; 44(7): 890-898.

https://doi.org/10.1093/ehjci/ehaa946.3192

15. Karkabi B, Meir G, Zafrir B, Jaffe R, Adawi S, Lavi I, et al. Door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Eur Heart J Qual Care Clin Outcomes. 2020;7(4):422-6. https://doi.org/10.1093/ehjqcco/qcaa037

16. Nishio R, Ogita M, Suwa S, Nakao K, Ozaki Y, Kimura K, et al. Shorter door-to-balloon time, better long-term clinical outcomes in ST-segment elevation myocardial infarction patients: J-MINUET substudy. J Cardiol 2023; 81(6): 564-70.

https://doi.org/10.1016/j.jjcc.2023.01.008

17. Marcusohn E, Reiner Benaim A, Ronen S, Kerner A, Beyar R, Almog R. Door to balloon time in primary percutaneous coronary intervention in ST elevation myocardial infarction: every minute counts. CAD 2022; 33(5): 341-348.

https://doi.org/10.1097/mca.0000000000001145

18. Foo CY, Bonsu KO, Nallamothu BK, Reid CM, Dhippayom T, Reidpath DD, et al. Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis. Heart 2018; 104(16): 1362-1369.

https://doi.org/10.1136/heartjnl-2017-312517

19. Khan N, Jan MW, Ullah R. The Influence of Presentation Timing and Door to Balloon Timing on the Clinical Outcomes in Primary Percutaneous Coronary Intervention: Influence of Presentation Timing and Door to Balloon Timing. Pak J Health Sci. 2023; 4(10): 181-186.

https://doi.org/10.54393/pjhs.v4i10.1125

20. Tsukui T, Sakakura K, Taniguchi Y, Yamamoto K, Seguchi M, Wada H, et al. Association between the door-to-balloon time and mid-term clinical outcomes in patients with ST-segment elevation myocardial infarction. Intern Med 2020; 59(13): 1597 603. https://doi.org/10.1371/journal.pone.0241836